Noveris Health Sciences Inc. (MYCOF)
Noveris Health Sciences Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.73, up 0.00% on the session, giving a market capitalisation of $42.7M. On trailing twelve-month figures it carries a trailing P/E of -70.00, a net margin of 0.0%. Its beta of -5.44 implies it has historically moved less than the broad market.
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.
Noveris Health Sciences Inc. is most often compared with the following Healthcare names: